Is adjuvant chemotherapy necessary for young women with early-stage epithelial ovarian cancer who have undergone fertility-sparing surgery?: a multicenter retrospective analysis

Is adjuvant chemotherapy necessary for young women with early-stage epithelial ovarian cancer who have undergone fertility-sparing surgery?: a multicenter retrospective analysis

Abstract Objective In young patients with early-stage epithelial ovarian carcinoma (EOC) who were received fertility-sparing surgery (FSS), the role of adjuvant chemotherapy is unclear. Here, we performed a multicenter study using inverse probability of treatment weighting (IPTW) to explore the effe...

Full description

Bibliographic Details
Main Authors: Yoshiki Ikeda, Masato Yoshihara, Nobuhisa Yoshikawa, Akira Yokoi, Satoshi Tamauchi, Kimihiro Nishino, Kaoru Niimi, Hiroaki Kajiyama
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Women's Health
Subjects:
Fertility
Carcinoma
Ovarian epithelial
Drug therapy
Propensity score
Online Access:https://doi.org/10.1186/s12905-022-01642-z

Internet

https://doi.org/10.1186/s12905-022-01642-z

Similar Items